Compare $APRE vs $FBLG | Chartloom

Compare

$APRE vs $FBLG

Aprea Therapeutics Inc · Fibrobiologics Inc

APRE

Aprea Therapeutics Inc

FBLG

Fibrobiologics Inc

Compare $APRE vs $FBLG

Comparing Aprea Therapeutics Inc and Fibrobiologics Inc

APREAprea Therapeutics Inc

FBLGFibrobiologics Inc

APREAprea Therapeutics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-99.4%

YTD performance

-29.1%

52W performance

-57.8%

FCF yield

-162.8%

FBLGFibrobiologics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.4%

52W performance

-88.8%

FCF yield

-215.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APRE

FBLG

Detailed metrics comparison

APRE

Aprea Therapeutics Inc

FBLG

Fibrobiologics Inc

Market Cap

APRE$7M

FBLG$7M

Enterprise Value

APRE$-34M

FBLG$3M

Price

APRE$0.60

FBLG$1.13

P/E Ratio

APREN/A

FBLGN/A

P/S Ratio

APRE1,438.94x

FBLG0.00x

EV/Sales

APRE-6,490.56x

FBLG0.00x

EV/EBITDA

APRE0.00x

FBLG0.00x

P/B Ratio

APRE0.22x

FBLG1.78x

P/FCF Ratio

APREN/A

FBLGN/A

EV/FCF

APRE2.77x

FBLG-0.24x

PEG Ratio

APREN/A

FBLGN/A

Forward P/E (NTM)

APREN/A

FBLGN/A

Forward P/S (NTM)

APREN/A

FBLGN/A

Revenue (TTM)

APRE$5K

FBLG$0

Revenue Growth (YoY)

APRE-99.4%

FBLGN/A

Forward Rev Growth

APRE445.8%

FBLG227.6%

Gross Margin (TTM)

APRE0.0%

FBLG0.0%

Operating Margin (TTM)

APRE0.0%

FBLG0.0%

EBITDA Margin (TTM)

APRE-253869.2%

FBLG0.0%

Net Margin (TTM)

APRE-236676.9%

FBLG0.0%

FCF Margin (TTM)

APRE-234296.2%

FBLGN/A

Net Income (TTM)

APRE$-12M

FBLG$-18M

FCF (TTM)

APRE$-12M

FBLG$-15M

EPS (TTM)

APRE-$0.23

FBLG-$2.89

ROE (TTM)

APRE-4630.0%

FBLG-53678.0%

ROA (TTM)

APRE-4097.0%

FBLG-22512.0%

ROIC (TTM)

APRE-4630.0%

FBLG-39304.0%

Cash

APRE$41M

FBLG$4M

Debt

APRE$0

FBLG$124K

Net Cash/Debt

APRE$41M

FBLG$3M

Current Ratio (TTM)

APRE13.55x

FBLG2.64x

Quick Ratio (TTM)

APRE13.33x

FBLG2.40x

Debt/Equity (TTM)

APRE0.00x

FBLG0.03x

Debt/Assets (TTM)

APRE0.0%

FBLG0.0%

Interest Coverage (TTM)

APREN/A

FBLGN/A

Net Debt/EBITDA (TTM)

APRE0.00x

FBLG0.00x

Beta

APRE-1.23

FBLG1.79

52W Performance

APRE-57.8%

FBLG-88.8%

YTD Performance

APRE-29.1%

FBLG-76.4%

% from 52W High

APRE-64.2%

FBLG-89.0%

% from 52W Low

APRE10.3%

FBLG82.3%

Asset Turnover (TTM)

APRE0.02x

FBLG0.00x

FCF Yield (TTM)

APRE-162.8%

FBLG-215.4%

Earnings Yield (TTM)

APRE-164.5%

FBLG-264.0%

Dividend Yield (TTM)

APREN/A

FBLGN/A

Rule of 40

APRE-234,395.5

FBLG0.0

EV/GP/RG

APREN/A

FBLGN/A

Ticker research

View APRE research View FBLG research

Metric	APRE Aprea Therapeutics Inc	FBLG Fibrobiologics Inc
Market & Valuation
Market Cap	$7M	$7M
Enterprise Value	$-34M	$3M
Price	$0.60	$1.13
P/E Ratio	N/A	N/A
P/S Ratio	1,438.94x	0.00x
EV/Sales	-6,490.56x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.22x	1.78x
P/FCF Ratio	N/A	N/A
EV/FCF	2.77x	-0.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5K	$0
Revenue Growth (YoY)	-99.4%	N/A
Forward Rev Growth	445.8%	227.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-253869.2%	0.0%
Net Margin (TTM)	-236676.9%	0.0%
FCF Margin (TTM)	-234296.2%	N/A
Net Income (TTM)	$-12M	$-18M
FCF (TTM)	$-12M	$-15M
EPS (TTM)	-$0.23	-$2.89
ROE (TTM)	-4630.0%	-53678.0%
ROA (TTM)	-4097.0%	-22512.0%
ROIC (TTM)	-4630.0%	-39304.0%
Financial Health
Cash	$41M	$4M
Debt	$0	$124K
Net Cash/Debt	$41M	$3M
Current Ratio (TTM)	13.55x	2.64x
Quick Ratio (TTM)	13.33x	2.40x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.23	1.79
52W Performance	-57.8%	-88.8%
YTD Performance	-29.1%	-76.4%
% from 52W High	-64.2%	-89.0%
% from 52W Low	10.3%	82.3%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-162.8%	-215.4%
Earnings Yield (TTM)	-164.5%	-264.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-234,395.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APRE research	View FBLG research

Valuation

P/S Ratio

FBLG

0.00x

APRE

1,438.94x

EV/FCF

FBLG

-0.24x

APRE

2.77x

Growth & revenue

Revenue Growth TTM

APRE

-99.4%

Forward Revenue Growth

APRE

445.8%

FBLG

227.6%

Profitability & performance

Gross Margin

APRE

0.0%

FBLG

0.0%

ROE

APRE

-4630.0%

FBLG

-53678.0%

FCF Yield %

APRE

-162.8%

FBLG

-215.4%

52-Week Performance

APRE

-57.8%

FBLG

-88.8%

Detailed metrics comparison

APRE

Aprea Therapeutics Inc

FBLG

Fibrobiologics Inc

Market Cap

APRE$7M

FBLG$7M

Enterprise Value

APRE$-34M

FBLG$3M

Price

APRE$0.60

FBLG$1.13

P/E Ratio

APREN/A

FBLGN/A

P/S Ratio

APRE1,438.94x

FBLG0.00x

EV/Sales

APRE-6,490.56x

FBLG0.00x

EV/EBITDA

APRE0.00x

FBLG0.00x

P/B Ratio

APRE0.22x

FBLG1.78x

P/FCF Ratio

APREN/A

FBLGN/A

EV/FCF

APRE2.77x

FBLG-0.24x

PEG Ratio

APREN/A

FBLGN/A

Forward P/E (NTM)

APREN/A

FBLGN/A

Forward P/S (NTM)

APREN/A

FBLGN/A

Revenue (TTM)

APRE$5K

FBLG$0

Revenue Growth (YoY)

APRE-99.4%

FBLGN/A

Forward Rev Growth

APRE445.8%

FBLG227.6%

Gross Margin (TTM)

APRE0.0%

FBLG0.0%

Operating Margin (TTM)

APRE0.0%

FBLG0.0%

EBITDA Margin (TTM)

APRE-253869.2%

FBLG0.0%

Net Margin (TTM)

APRE-236676.9%

FBLG0.0%

FCF Margin (TTM)

APRE-234296.2%

FBLGN/A

Net Income (TTM)

APRE$-12M

FBLG$-18M

FCF (TTM)

APRE$-12M

FBLG$-15M

EPS (TTM)

APRE-$0.23

FBLG-$2.89

ROE (TTM)

APRE-4630.0%

FBLG-53678.0%

ROA (TTM)

APRE-4097.0%

FBLG-22512.0%

ROIC (TTM)

APRE-4630.0%

FBLG-39304.0%

Cash

APRE$41M

FBLG$4M

Debt

APRE$0

FBLG$124K

Net Cash/Debt

APRE$41M

FBLG$3M

Current Ratio (TTM)

APRE13.55x

FBLG2.64x

Quick Ratio (TTM)

APRE13.33x

FBLG2.40x

Debt/Equity (TTM)

APRE0.00x

FBLG0.03x

Debt/Assets (TTM)

APRE0.0%

FBLG0.0%

Interest Coverage (TTM)

APREN/A

FBLGN/A

Net Debt/EBITDA (TTM)

APRE0.00x

FBLG0.00x

Beta

APRE-1.23

FBLG1.79

52W Performance

APRE-57.8%

FBLG-88.8%

YTD Performance

APRE-29.1%

FBLG-76.4%

% from 52W High

APRE-64.2%

FBLG-89.0%

% from 52W Low

APRE10.3%

FBLG82.3%

Asset Turnover (TTM)

APRE0.02x

FBLG0.00x

FCF Yield (TTM)

APRE-162.8%

FBLG-215.4%

Earnings Yield (TTM)

APRE-164.5%

FBLG-264.0%

Dividend Yield (TTM)

APREN/A

FBLGN/A

Rule of 40

APRE-234,395.5

FBLG0.0

EV/GP/RG

APREN/A

FBLGN/A

Ticker research

View APRE research View FBLG research

Metric	APRE Aprea Therapeutics Inc	FBLG Fibrobiologics Inc
Market & Valuation
Market Cap	$7M	$7M
Enterprise Value	$-34M	$3M
Price	$0.60	$1.13
P/E Ratio	N/A	N/A
P/S Ratio	1,438.94x	0.00x
EV/Sales	-6,490.56x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.22x	1.78x
P/FCF Ratio	N/A	N/A
EV/FCF	2.77x	-0.24x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5K	$0
Revenue Growth (YoY)	-99.4%	N/A
Forward Rev Growth	445.8%	227.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-253869.2%	0.0%
Net Margin (TTM)	-236676.9%	0.0%
FCF Margin (TTM)	-234296.2%	N/A
Net Income (TTM)	$-12M	$-18M
FCF (TTM)	$-12M	$-15M
EPS (TTM)	-$0.23	-$2.89
ROE (TTM)	-4630.0%	-53678.0%
ROA (TTM)	-4097.0%	-22512.0%
ROIC (TTM)	-4630.0%	-39304.0%
Financial Health
Cash	$41M	$4M
Debt	$0	$124K
Net Cash/Debt	$41M	$3M
Current Ratio (TTM)	13.55x	2.64x
Quick Ratio (TTM)	13.33x	2.40x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.23	1.79
52W Performance	-57.8%	-88.8%
YTD Performance	-29.1%	-76.4%
% from 52W High	-64.2%	-89.0%
% from 52W Low	10.3%	82.3%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-162.8%	-215.4%
Earnings Yield (TTM)	-164.5%	-264.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-234,395.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APRE research	View FBLG research